Similar articles

• Regulation of angiogenesis via vascular endothelial growth factor receptors.

  Veikkola T, Karkkainen M, Claesson-Welsh L, Alitalo K. Veikkola T, et al. Cancer Res. 2000 Jan 15;60(2):203-12. Cancer Res. 2000. PMID: 10667560 Review. No abstract available.
• Vascular endothelial growth factor: a key mediator of neoangiogenesis. A review.

  Amoroso A, Del Porto F, Di Monaco C, Manfredini P, Afeltra A. Amoroso A, et al. Eur Rev Med Pharmacol Sci. 1997 Jan-Jun;1(1-3):17-25. Eur Rev Med Pharmacol Sci. 1997. PMID: 9444794 Review.
• Stimulation of peripheral angiogenesis by vascular endothelial growth factor (VEGF).

  Baumgartner I, Isner JM. Baumgartner I, et al. Vasa. 1998 Nov;27(4):201-6. Vasa. 1998. PMID: 9859738 Review.
• Clinical applications of angiogenic growth factors and their inhibitors.

  Ferrara N, Alitalo K. Ferrara N, et al. Nat Med. 1999 Dec;5(12):1359-64. doi: 10.1038/70928. Nat Med. 1999. PMID: 10581076 Review.
• [The hypoxia-inducible factor HIF as a new target in cancer research].

  L'Allemain G. L'Allemain G. Bull Cancer. 2002 Mar;89(3):257-60. Bull Cancer. 2002. PMID: 11940464 Review. French.